Neoadjuvant chemotherapy versus standard treatment in patients with locally advanced colon cancer (NeoCol)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-514294-22-01

Acronym

NeoCol

Enrollment

247

Registered

2024-09-27

Start date

2013-10-14

Completion date

Unknown

Last updated

2024-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon cancer

Brief summary

Two-year disease free survival

Interventions

DRUGCAPECITABINE

DRUGOXALIPLATIN

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Two-year disease free survival	—

Countries

Denmark, Norway

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026